Related references
Note: Only part of the references are listed.Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks
Rui Xue Zhang et al.
NANOSCALE (2017)
The development of RAPTA compounds for the treatment of tumors
Benjamin S. Murray et al.
COORDINATION CHEMISTRY REVIEWS (2016)
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Metal Complexes and Their Effect at the Cellular Level
Christina N. Banti et al.
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY (2016)
Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery
Xiao Yu Wu
EXPERT OPINION ON DRUG DELIVERY (2016)
Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination
Yi-Nan Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Axially-modified paddlewheel diruthenium(II,III)-ibuprofenato metallodrugs and the influence of the structural modification on U87MG and A172 human glioma cell proliferation, apoptosis, mitosis and migration
Hanif-Ur-Rehman et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2016)
Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor
Rui Xue Zhang et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
Design of Hybrid MnO2-Polymer-Lipid Nanoparticles with Tunable Oxygen Generation Rates and Tumor Accumulation for Cancer Treatment
Claudia R. Gordijo et al.
ADVANCED FUNCTIONAL MATERIALS (2015)
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Alberta Bergamo et al.
CHEMICAL SOCIETY REVIEWS (2015)
Nanoparticle colloidal stability in cell culture media and impact on cellular interactions
Thomas L. Moore et al.
CHEMICAL SOCIETY REVIEWS (2015)
Self-assembly of myristic acid in the presence of choline hydroxide: Effect of molar ratio and temperature
Audrey Arnould et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2015)
Manganese oxide and docetaxel co-loaded fluorescent polymer nanoparticles for dualmodal imaging and chemotherapy of breast cancer
Azhar Z. Abbasi et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Spectroscopic studies on interactions of the tetrakis(acetato) chloridodiruthenium(II,III) complex and the Ru2(II,III)-NSAID-derived metallodrugs of ibuprofen and ketoprofen with human serum albumin
Rodrigo Luis Silva Ribeiro Santos et al.
JOURNAL OF COORDINATION CHEMISTRY (2015)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
Elvin Blanco et al.
NATURE BIOTECHNOLOGY (2015)
RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells
Dan Shan et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2015)
Unusual Structural Features in the Lysozyme Derivative of the Tetrakis(acetato)chloridodiruthenium(II,III) Complex
Luigi Messori et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
NSAIDs Inhibit Tumorigenesis, but How?
Evrim Gurpinar et al.
CLINICAL CANCER RESEARCH (2014)
Growth inhibitory effects of the Diruthenium-Ibuprofen compound, [Ru2Cl(Ibp)4], in human glioma cells in vitro and in the rat C6 orthotopic glioma in vivo
Marcel Benadiba et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2014)
Nanoformulation Improves Activity of the (pre)Clinical Anticancer Ruthenium Complex KP1019
P. Heffeter et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Synergistic Nanoparticulate Drug Combination Overcomes Multidrug Resistance, Increases Efficacy, and Reduces Cardiotoxicity in a Nonimmunocompromised Breast Tumor Model
Adam J. Shuhendler et al.
MOLECULAR PHARMACEUTICS (2014)
Secretion of intestinal goblet cells: A novel excretion pathway of nanoparticles
Baoquan Zhao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
Robert Trondl et al.
CHEMICAL SCIENCE (2014)
Nanocarriers for delivery of platinum anticancer drugs
Hardeep S. Oberoi et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts
Preethy Prasad et al.
CANCER LETTERS (2013)
Targeting and delivery of platinum-based anticancer drugs
Xiaoyong Wang et al.
CHEMICAL SOCIETY REVIEWS (2013)
Kinetic and mechanistic studies on reactions of diruthenium(II,III) with biologically relevant reducing agents
Rodrigo Luis Silva Ribeiro Santos et al.
DALTON TRANSACTIONS (2013)
Deciphering the mechanisms of cellular uptake of engineered nanoparticles by accurate evaluation of internalization using imaging flow cytometry
Sandra Vranic et al.
PARTICLE AND FIBRE TOXICOLOGY (2013)
Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Denise de Oliveira Silva
Anti-Cancer Agents in Medicinal Chemistry (2012)
Thermodynamics of Axial Substitution and Kinetics of Reactions with Amino Acids for the Paddlewheel Complex Tetrakis(acetato)chloridodiruthenium(II,III)
Rodrigo L. S. R. Santos et al.
INORGANIC CHEMISTRY (2012)
Thermally-triggered 'off-on-off' response of gadolinium-hydrogel-lipid hybrid nanoparticles defines a customizable temperature window for non-invasive magnetic resonance imaging thermometry
Adam J. Shuhendler et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
A. Bergamo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Synthesis and characterization of a diruthenium(II,III)-ketoprofen compound and study of the in vitro effects on CRC cells in comparison to the naproxen and ibuprofen derivatives
Rodrigo L. S. R. Santos et al.
POLYHEDRON (2012)
A Novel Solid Lipid Nanoparticle Formulation for Active Targeting to Tumor αvβ3 Integrin Receptors Reveals Cyclic RGD as A Double-Edged Sword
Adam J. Shuhendler et al.
ADVANCED HEALTHCARE MATERIALS (2012)
A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells
Preethy Prasad et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)
Treating metastatic cancer with nanotechnology
Avi Schroeder et al.
NATURE REVIEWS CANCER (2012)
Hybrid Quantum Dot-Fatty Ester Stealth Nanoparticles: Toward Clinically Relevant in Vivo Optical Imaging of Deep Tissue
Adam J. Shuhendler et al.
ACS NANO (2011)
A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells
Adam J. Shuhendler et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
The novel ruthenium-gamma-linolenic complex [Ru-2(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro
Geise Ribeiro et al.
CELL BIOCHEMISTRY AND FUNCTION (2010)
Inhibition of C6 rat glioma proliferation by [Ru2Cl(Ibp)(4)] depends on changes in p21, p27, Bax/Bcl2 ratio and mitochondrial membrane potential
Marcel Benadiba et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2010)
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells
Hiromi Hanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Diruthenium(II, III) complexes of ibuprofen, aspirin, naproxen and indomethacin non-steroidal anti-inflammatory drugs: Synthesis, characterization and their effects on tumor-cell proliferation
Geise Ribeiro et al.
POLYHEDRON (2008)
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles
Ho Lun Wong et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
The design of organometallic ruthenium arene anticancer agents
Sarah J. Dougan et al.
CHIMIA (2007)
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new Polymer-Lipid Hybrid Nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer
Ho Lun Wong et al.
JOURNAL OF CONTROLLED RELEASE (2006)
A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells
Ho Lun Wong et al.
PHARMACEUTICAL RESEARCH (2006)
From bench to bedside -: preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA
HT Chifotides et al.
ACCOUNTS OF CHEMICAL RESEARCH (2005)
Ruthenium antimetastatic agents
E Alessio et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
MJ Thun et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Effect of protonation on the solution and phase behavior of aqueous sodium myristate
XY Wen et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2000)
Synthesis and characterization of a diruthenium-ibuprofenato complex -: Comparing its anti-inflammatory activity with that of a copper(II)-ibuprofenato complex
A Andrade et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2000)
Share Paper
